Legend Biotech's total assets for Q4 2024 were $1.67B, a decrease of -3.78% from the previous quarter. LEGN total liabilities were $629.61M for the fiscal quarter, a 1.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.